Pipeline

A Pipeline of First-in-Class Adipose-Targeted Therapies

Moonwalk is advancing a portfolio of adipose-targeted siRNA therapeutics across obesity and cardiometabolic diseases.

Indication
Mechanism
Discovery
Target validation
Preclinical candidate
IND-enabling (DC)
Clinical
MW01
Indication:
Obesity
Stage: IND-enabling (DC)
Late 2027
MW08
Indication:
Obesity
Mechanism:
Stage: Preclinical candidate
MW05
Indication:
Lipid lowering
Stage: Preclinical candidate
MW09
Indication:
Obesity
Stage: Preclinical candidate
MWₙ
Indication:
Obesity and other indications
Stage: Target validation